Top Story

ANRS CO23 CULPIT: Sovaldi, daclatasvir well tolerated in transplant, recurrence

ANRS CO23 CULPIT: Sovaldi, daclatasvir well tolerated in transplant, recurrence
April 26, 2015

VIENNA — Regimens containing Sovaldi and daclatasvir were efficacious and well tolerated in a cohort of patients with recurrence of hepatitis C virus after liver transplantation, according to data presented at the 2015 International Liver Congress.

Audrey Coilly, MD, of AP-HP Hopital Paul Brousse, University of Paris-Sud, Institut National de la Santé et Recherche Médicale in Villejuif, Paris, said that HCV recurrence in transplant patients used to be a major issue. “Access to new [direct-acting antivirals] revolutionizes the prognosis of these patients,” she said.

Meeting News Coverage

PNPLA3 variation prevalent in alcoholic liver disease

April 26, 2015
VIENNA — In a genome-wide association study, researchers found the PNPLA3 variation to be very prominent in alcoholic liver disease, and TM6SF2 and…
Meeting News Coverage

IMAGO: LUM001 fails to reduce bile acids, pruritus in pediatric patients with ALGS

April 26, 2015
VIENNA — Serum bile acids and pruritus remained unchanged in pediatric patients with allagile syndrome after treatment with LUM001, according to a late breaker…
Meeting News Coverage

ALLY-1: transplant patients, those with cirrhosis achieve SVR12 with daclatasvir, sofosbuvir

April 26, 2015
VIENNA — A regimen containing Sovaldi and daclatasvir was associated with favorable 12-week sustained virologic response rates in a cohort of patients with…
Meeting News Coverage

Oligonucleotide injection reduced HCV viral load

April 26, 2015
VIENNA — Injection of an oligonucleotide with activity against microRNA-122 led to undetectable viral load in a cohort of HCV patients of multiple genotypes…
More News Headlines »
CME
HCV Consults: Volume 1, Number 3

HCV Consults: Volume 1, Number 3

This activity is supported by educational grants from AbbVie and Genentech, Inc.

More »
Meeting News Coverage Video
VIDEO: 2DMRE accurately predicts advanced fibrosis in patients with NAFLD

VIDEO: 2DMRE accurately predicts advanced fibrosis in patients with NAFLD

April 24, 2015
VIENNA — Jeffrey Y. Cui, fourth year medical student in the NAFLD Translational Research Unit at University of…
More »
CME
HCV Consults: Volume 1, Number 2

HCV Consults: Volume 1, Number 2

This activity is supported by educational grants from AbbVie and Genentech.

Approved interferon-free therapy has already become entrenched among clinicians for patients with HCV genotypes 2 and…
More »
morganatic-roan